Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Foetal methylmercury syndrome is characterized by a group of symptoms that may be observed in a fetus or newborn when the mother was exposed during pregnancy to excessive amounts of methylmercury.
Biomarker and diagnostic research for fetal methylmercury syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for fetal methylmercury syndrome.
43 publications have been identified in PubMed for fetal methylmercury syndrome. Research spans Basic Science / Preclinical (53%), Epidemiology / Natural History (19%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 23 | 53% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:35 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
8 |
19% |
Research summaries | 7 | 16% |
Other research | 3 | 7% |
Testing and diagnosis research | 1 | 2% |
Patient case studies | 1 | 2% |
Yamashita N (2026). [PMID: 41621855](https://pubmed.ncbi.nlm.nih.gov/41621855/). *J Toxicol Sci*. [Basic Science / Preclinical]
Yorifuji T (2026). [PMID: 41765117](https://pubmed.ncbi.nlm.nih.gov/41765117/). *Neurotoxicol Teratol*. [Epidemiology / Natural History]
Yamashiro K (2026). [PMID: 41621859](https://pubmed.ncbi.nlm.nih.gov/41621859/). *J Toxicol Sci*. [Basic Science / Preclinical]
Hamaoka Y (2026). [PMID: 42206940](https://pubmed.ncbi.nlm.nih.gov/42206940/). *Ann ICRP*. [Other]
Haraguchi K (2026). [PMID: 42191295](https://pubmed.ncbi.nlm.nih.gov/42191295/). *Anal Chim Acta*. [Other]
Marchi E (2026). [PMID: 41746958](https://pubmed.ncbi.nlm.nih.gov/41746958/). *PLoS One*. [Basic Science / Preclinical]
Varão MVS (2026). [PMID: 42049180](https://pubmed.ncbi.nlm.nih.gov/42049180/). *Arq Neuropsiquiatr*. [Epidemiology / Natural History]
Shinoda Y (2026). [PMID: 41922269](https://pubmed.ncbi.nlm.nih.gov/41922269/). *J Toxicol Sci*. [Basic Science / Preclinical]
Parvez SM (2026). [PMID: 42035336](https://pubmed.ncbi.nlm.nih.gov/42035336/). *Int J Environ Health Res*. [Epidemiology / Natural History]
Wang J (2026). [PMID: 41494414](https://pubmed.ncbi.nlm.nih.gov/41494414/). *Mar Pollut Bull*. [Basic Science / Preclinical]